Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency
Sponsor: Sclnow Biotechnology Co., Ltd.
Summary
Evaluate the safety of human umbilical cord mesenchymal stem cells (hucMSCs) in POI treatment; Evaluate the effective hucMSCs in POI treatment. Compare different infusion mode, meanwhile compare with hormone replacement therapy (HRT) withdrawal, so that assessing the stem cell therapy.
Official title: Clinical Study on the Safety and Effectiveness of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency
Key Details
Gender
FEMALE
Age Range
19 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2018-10-01
Completion Date
2027-06-30
Last Updated
2026-04-23
Healthy Volunteers
No
Conditions
Interventions
hucMSCs
Human umbilical cord mesenchymal stem cells were transplanted by intravenous infusion
Locations (1)
Henan Provincial People's Hospital
Zhengzhou, Henan, China